Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
111.31
+3.09 (2.86%)
At close: Aug 18, 2026, 4:00 PM EDT
109.09
-2.22 (-1.99%)
After-hours: Aug 18, 2026, 4:29 PM EDT
Veradermics Employees
Veradermics had 37 employees as of June 30, 2026.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,818,649
Market Cap
4.65B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 37 | - | - |
| Mar 31, 2026 | 24 | - | - |
| Dec 31, 2025 | 21 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Dyne Therapeutics | 289 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
| Parabilis Medicines | 145 |
| Tango Therapeutics | 137 |
MANE News
- 7 days ago - Veradermics Earnings release: Q2 2026 - Filings
- 7 days ago - Veradermics Quarterly report: Q2 2026 - Filings
- 7 days ago - Veradermics sees cash runway into 2030 - TheFly
- 7 days ago - Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year - TheFly
- 7 days ago - Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - Business Wire
- 10 days ago - Veradermics registers to sell 16.77M shares of common stock - TheFly
- 11 days ago - Veradermics Registration statement: Registration filing - Filings
- 4 weeks ago - Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study - TheFly